Related Experiment Video

Updated: May 30, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy?

Anne E Barden1, Tomas B Corcoran, Emilie Mas

  • 1School of Medicine and Pharmacology, Cardiovascular Research Centre, University of Western Australia, Perth. anne.barden@uwa.edu.au

Antioxidants & Redox Signaling
|August 11, 2011
PubMed

Insights

Pre-eclampsia is linked to higher levels of isofurans and F(4)-neuroprostanes in mothers and newborns. These lipid oxidation products may impact fetal development and birth weight in pregnancies.

Area of Science:

  • Reproductive Biology
  • Biochemistry
  • Perinatal Medicine

Background:

  • Pre-eclampsia is a serious pregnancy complication affecting maternal and fetal health.
  • Essential fatty acids like arachidonic and docosahexaenoic acid can oxidize into F(2)-isoprostanes (F(2)-IsoPs), isofurans (IsoFs), and F(4)-neuroprostanes (F(4)-NeuroPs).
  • These oxidized metabolites may play a role in pre-eclampsia and fetal development.

Purpose of the Study:

  • To investigate the levels of IsoFs, F(4)-NeuroPs, and F(2)-IsoPs in maternal and cord blood plasma.
  • To determine the association of these lipid oxidation products with pre-eclampsia and birth weight.

Main Methods:

  • Analysis of IsoFs, F(4)-NeuroPs, and F(2)-IsoPs in maternal and cord blood plasma samples.
  • Comparison of metabolite levels between women with pre-eclampsia and normal pregnancies.
  • Statistical analysis to assess relationships between metabolites, gestational age, and birth weight.

Main Results:

  • Maternal plasma showed significantly elevated levels of IsoFs and F(4)-NeuroPs in women with pre-eclampsia, but not F(2)-IsoPs.
  • Cord blood plasma revealed elevated F(4)-NeuroPs in neonates born to mothers with pre-eclampsia.
  • In normal pregnancies, maternal F(2)-IsoPs, IsoFs, and F(4)-NeuroPs were inversely related to birth weight.

Conclusions:

  • IsoFs and F(4)-NeuroPs are elevated in maternal circulation and F(4)-NeuroPs in cord blood of women with pre-eclampsia.
  • Maternal lipid oxidation products may serve as predictors of low birth weight in normal pregnancies.
  • Further research is needed to explore the predictive value of these markers for pregnancy complications in early gestation.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...